Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02322177 · ClinicalTrials.gov registry record
Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
A clinical trial of Pregnancy and Inborn Errors of Metabolism, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 2
- Enrollment target
- 2
- Study locations
NCT02322177 is a study of Pregnancy and Inborn Errors of Metabolism that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 2 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02322177, a study of Pregnancy and Inborn Errors of Metabolism, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with an inborn error of metabolism. Also, to create a pregnancy registry of inborn errors of metabolism. Eligibility: * Women with an inborn error of metabolism who either: * have been pregnant in the past, * are currently pregnant, or * have recently talked with their doctor about becoming pregnant. Design: * This study will collect data only. No extra tests will be done. * Participants will be in the study for the length of their pregnancy and for 1 year after delivery. * Participants will answer questions about their family s health. * The participant s doctor will send their medical records to researchers. These may include data about: * Last health care visit before pregnancy * Blood, urine, ultrasound, or lab results during pregnancy * Delivery and recovery after delivery * Researchers will ask for the test(s) used to confirm pregnancy. * After the participant has her baby, researchers will ask for data about how the baby is doing. This may include when the baby is sitting, walking, talking, etc. * The data will be placed into a database. The database will not include the participant s name or identifying data.
Conditions Studied
Study Locations (2)
Maryland
- National Human Genome Research Institute (NHGRI) - Bethesda
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-12-19 |
| Est. Completion | 2018-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02322177
The ClinicalTrials.gov registry entry for NCT02322177 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (100% lower). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.
NCT02322177 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02322177 about?
NCT02322177 is a clinical study titled "Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol". Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with ...
What is the current status of trial NCT02322177?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2014-12-19. Estimated completion is 2018-08-20.
What conditions does trial NCT02322177 study?
This clinical trial studies the following conditions: Pregnancy, Inborn Errors of Metabolism, Acidemias.
Who is sponsoring clinical trial NCT02322177?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02322177 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.